Centre d'appui pour la prévention des infections associées aux soins d'Ile de France, Assistance Publique-Hôpitaux de Paris, Paris, France.
Unité de Prévention et de Lutte contre les Infections Nosocomiales, CHU d'Angers, Université d'Angers, Angers, France.
Clin Microbiol Infect. 2018 Nov;24(11):1130-1138. doi: 10.1016/j.cmi.2018.03.034. Epub 2018 Mar 29.
Hospital-acquired infections (HAIs) are a major public health issue. The potential of antimicrobial copper surfaces in reducing HAIs' rates is of interest but remains unclear. We conducted a systematic review of studies assessing the activity of copper surfaces (colony-forming unit (CFU)/surface, both in vitro and in situ) as well as clinical studies. In vitro study protocols were analysed through a tailored checklist developed specifically for this review, in situ studies and non-randomized clinical studies were assessed using the ORION (Outbreak Reports and Intervention studies Of Nosocomial infection) checklist and randomized clinical studies using the CONSORT guidelines.
The search was conducted using PubMed database with the keywords 'copper' and 'surfaces' and 'healthcare associated infections' or 'antimicrobial'. References from relevant articles, including reviews, were assessed and added when appropriate. Articles were added until 30 August 2016. Overall, 20 articles were selected for review including 10 in vitro, eight in situ and two clinical studies.
Copper surfaces were found to have variable antimicrobial activity both in vitro and in situ, although the heterogeneity in the designs and the reporting of the results prevented conclusions from being drawn regarding their spectrum and activity/time compared to controls. Copper effect on HAIs incidence remains unclear because of the limited published data and the lack of robust designs. Most studies have potential conflicts of interest with copper industries.
Copper surfaces have demonstrated an antimicrobial activity but the implications of this activity in healthcare settings are still unclear. No clear effect on healthcare associated infections has been demonstrated yet.
医院获得性感染(HAI)是一个主要的公共卫生问题。抗菌铜表面在降低 HAI 发生率方面的潜力引起了人们的关注,但目前仍不清楚。我们对评估铜表面(菌落形成单位(CFU)/表面,无论是在体外还是在原位)活性的研究以及临床研究进行了系统评价。通过专门为此审查制定的定制清单分析了体外研究方案,使用 ORION(医院感染暴发报告和干预研究)清单评估了原位研究和非随机临床研究,并使用 CONSORT 指南评估了随机临床研究。
使用 PubMed 数据库,使用关键字“铜”和“表面”以及“医疗保健相关感染”或“抗菌”进行搜索。评估了相关文章的参考文献,并在适当的情况下添加了参考文献。文章的添加时间截至 2016 年 8 月 30 日。总共选择了 20 篇文章进行综述,其中包括 10 篇体外研究、8 篇原位研究和 2 篇临床研究。
铜表面在体外和原位均表现出不同的抗菌活性,尽管设计和结果报告的异质性使得无法得出关于其与对照物的光谱和活性/时间的结论。由于发表的数据有限且设计缺乏稳健性,因此铜对 HAI 发生率的影响仍不清楚。大多数研究都存在与铜工业相关的潜在利益冲突。
铜表面具有抗菌活性,但这种活性在医疗保健环境中的影响仍不清楚。尚未证明对医疗保健相关感染有明确的影响。